Cargando…

Cranial organs at risk delineation: heterogenous practices in radiotherapy planning

BACKGROUND: Segmentation is a crucial step in treatment planning that directly impacts dose distribution and optimization. The aim of this study was to evaluate the inter-individual variability of common cranial organs at risk (OAR) delineation in neurooncology practice. METHODS: Anonymized simulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogin, Guillaume, Hettal, Liza, Bartau, Clarisse, Thariat, Juliette, Claeys, Marie-Virginie, Peyraga, Guillaume, Retif, Paul, Schick, Ulrike, Antoni, Delphine, Bodgal, Zsuzsa, Dhermain, Frederic, Feuvret, Loic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863275/
https://www.ncbi.nlm.nih.gov/pubmed/33541394
http://dx.doi.org/10.1186/s13014-021-01756-y
_version_ 1783647462322339840
author Vogin, Guillaume
Hettal, Liza
Bartau, Clarisse
Thariat, Juliette
Claeys, Marie-Virginie
Peyraga, Guillaume
Retif, Paul
Schick, Ulrike
Antoni, Delphine
Bodgal, Zsuzsa
Dhermain, Frederic
Feuvret, Loic
author_facet Vogin, Guillaume
Hettal, Liza
Bartau, Clarisse
Thariat, Juliette
Claeys, Marie-Virginie
Peyraga, Guillaume
Retif, Paul
Schick, Ulrike
Antoni, Delphine
Bodgal, Zsuzsa
Dhermain, Frederic
Feuvret, Loic
author_sort Vogin, Guillaume
collection PubMed
description BACKGROUND: Segmentation is a crucial step in treatment planning that directly impacts dose distribution and optimization. The aim of this study was to evaluate the inter-individual variability of common cranial organs at risk (OAR) delineation in neurooncology practice. METHODS: Anonymized simulation contrast-enhanced CT and MR scans of one patient with a solitary brain metastasis was used for delineation and analysis. Expert professionals from 16 radiotherapy centers involved in brain structures delineation were asked to segment 9 OAR on their own treatment planning system. As reference, two experts in neurooncology, produced a unique consensual contour set according to guidelines. Overlap ratio, Kappa index (KI), volumetric ratio, Commonly Contoured Volume, Supplementary Contoured Volume were evaluated using Artiview™ v 2.8.2—according to occupation, seniority and level of expertise of all participants. RESULTS: For the most frequently delineated and largest OAR, the mean KI are often good (0.8 for the parotid and the brainstem); however, for the smaller OAR, KI degrade (0.3 for the optic chiasm, 0.5% for the cochlea), with a significant discrimination (p < 0.01). The radiation oncologists, members of Association des Neuro-Oncologue d’Expression Française society performed better in all indicators compared to non-members (p < 0.01). Our exercise was effective in separating the different participating centers with 3 of the reported indicators (p < 0.01). CONCLUSION: Our study illustrates the heterogeneity in normal structures contouring between professionals. We emphasize the need for cerebral OAR delineation harmonization—that is a major determinant of therapeutic ratio and clinical trials evaluation.
format Online
Article
Text
id pubmed-7863275
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78632752021-02-05 Cranial organs at risk delineation: heterogenous practices in radiotherapy planning Vogin, Guillaume Hettal, Liza Bartau, Clarisse Thariat, Juliette Claeys, Marie-Virginie Peyraga, Guillaume Retif, Paul Schick, Ulrike Antoni, Delphine Bodgal, Zsuzsa Dhermain, Frederic Feuvret, Loic Radiat Oncol Research BACKGROUND: Segmentation is a crucial step in treatment planning that directly impacts dose distribution and optimization. The aim of this study was to evaluate the inter-individual variability of common cranial organs at risk (OAR) delineation in neurooncology practice. METHODS: Anonymized simulation contrast-enhanced CT and MR scans of one patient with a solitary brain metastasis was used for delineation and analysis. Expert professionals from 16 radiotherapy centers involved in brain structures delineation were asked to segment 9 OAR on their own treatment planning system. As reference, two experts in neurooncology, produced a unique consensual contour set according to guidelines. Overlap ratio, Kappa index (KI), volumetric ratio, Commonly Contoured Volume, Supplementary Contoured Volume were evaluated using Artiview™ v 2.8.2—according to occupation, seniority and level of expertise of all participants. RESULTS: For the most frequently delineated and largest OAR, the mean KI are often good (0.8 for the parotid and the brainstem); however, for the smaller OAR, KI degrade (0.3 for the optic chiasm, 0.5% for the cochlea), with a significant discrimination (p < 0.01). The radiation oncologists, members of Association des Neuro-Oncologue d’Expression Française society performed better in all indicators compared to non-members (p < 0.01). Our exercise was effective in separating the different participating centers with 3 of the reported indicators (p < 0.01). CONCLUSION: Our study illustrates the heterogeneity in normal structures contouring between professionals. We emphasize the need for cerebral OAR delineation harmonization—that is a major determinant of therapeutic ratio and clinical trials evaluation. BioMed Central 2021-02-04 /pmc/articles/PMC7863275/ /pubmed/33541394 http://dx.doi.org/10.1186/s13014-021-01756-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Vogin, Guillaume
Hettal, Liza
Bartau, Clarisse
Thariat, Juliette
Claeys, Marie-Virginie
Peyraga, Guillaume
Retif, Paul
Schick, Ulrike
Antoni, Delphine
Bodgal, Zsuzsa
Dhermain, Frederic
Feuvret, Loic
Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title_full Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title_fullStr Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title_full_unstemmed Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title_short Cranial organs at risk delineation: heterogenous practices in radiotherapy planning
title_sort cranial organs at risk delineation: heterogenous practices in radiotherapy planning
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863275/
https://www.ncbi.nlm.nih.gov/pubmed/33541394
http://dx.doi.org/10.1186/s13014-021-01756-y
work_keys_str_mv AT voginguillaume cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT hettalliza cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT bartauclarisse cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT thariatjuliette cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT claeysmarievirginie cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT peyragaguillaume cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT retifpaul cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT schickulrike cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT antonidelphine cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT bodgalzsuzsa cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT dhermainfrederic cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning
AT feuvretloic cranialorgansatriskdelineationheterogenouspracticesinradiotherapyplanning